MGP
PFE icon

Metis Global Partners’s Pfizer PFE Stock Holding History

Metis Global Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.37M Buy
181,310
+4,977
+3% +$130K 0.1% 153
2026
Q1 		$4.95M Sell
176,333
-19,925
-10% -$530K 0.12% 137
2025
Q4 		$4.89M Sell
196,258
-50,490
-20% -$1.27M 0.12% 150
2025
Q3 		$6.29M Sell
246,748
-34,728
-12% -$857K 0.15% 119
2025
Q2 		$6.82M Sell
281,476
-76,183
-21% -$1.78M 0.18% 97
2025
Q1 		$9.06M Buy
357,659
+33,039
+10% +$865K 0.25% 66
2024
Q4 		$8.61M Buy
324,620
+6,655
+2% +$181K 0.26% 58
2024
Q3 		$9.2M Buy
317,965
+6,002
+2% +$175K 0.29% 57
2024
Q2 		$8.73M Buy
311,963
+3,325
+1% +$91.5K 0.3% 56
2024
Q1 		$8.56M Buy
308,638
+3,889
+1% +$108K 0.31% 57
2023
Q4 		$8.77M Buy
304,749
+42,083
+16% +$1.27M 0.35% 52
2023
Q3 		$8.71M Buy
262,666
+38,492
+17% +$1.36M 0.42% 38
2023
Q2 		$8.22M Sell
224,174
-3,659
-2% -$142K 0.44% 35
2023
Q1 		$9.3M Buy
227,833
+62,398
+38% +$2.7M 0.6% 26
2022
Q4 		$8.48M Buy
165,435
+68,328
+70% +$3.28M 0.76% 23
2022
Q3 		$4.25M Buy
97,107
+4,783
+5% +$232K 0.68% 22
2022
Q2 		$4.84M Buy
92,324
+2,250
+2% +$115K 0.77% 19
2022
Q1 		$4.66M Buy
90,074
+38,192
+74% +$1.98M 0.56% 24
2021
Q4 		$3.06M Buy
+51,882
New +$2.57M 0.85% 16

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Metis Global Partners's PFE Position: Q2 2026 in Review

Metis Global Partners increased its Pfizer (PFE) stake by 2.8% in Q2 2026, buying an estimated $130K and bringing the position to 181,310 shares worth $4.37M. The position accounts for 0.1% of the portfolio, ranked #153.

Metis Global Partners first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $9.3M in Q1 2023. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Metis Global Partners held 181,310 shares of Pfizer worth $4.37M as of Q2 2026.
  • Metis Global Partners bought 4,977 Pfizer shares in Q2 2026, an estimated $130K.
  • Pfizer made up 0.1% of Metis Global Partners's portfolio in Q2 2026, its #153 holding.
  • Metis Global Partners first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Metis Global Partners's Pfizer position peaked at $9.3M in Q1 2023.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.